Positioning political buying, disclosed 2026-09-25
Options put/call open interest 0.21, read 2026-11-05
Ethical passes the values gate
Price285.51 USD
Fair value200.70
Ethical score86.8/100
Value readOvervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-05Read Markup297.69-4.1% to today Accumulation gives way to Markup after an 18% rise in 3 weeks
2026-10-18Read Accumulation252.40+13.1% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-10-11Read Markdown246.15+16.0% to today Distribution gives way to Markdown after a 13% slide in 14 weeks
2026-07-02Read Distribution281.38+1.5% to today First review on file: Distribution with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Vulcan Materials Company holds its Markup at $285.51. The statistical read favours the sellers, held for 157 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 157 days
Price at the screen
$285.51
Valuation
33.17 trailing · 27.51 forward price to earnings
Values screen
PASS· score 86.8
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
29.25%
Below 33%
Interest-bearing debt is just 29.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.20%
Below 33%
Cash held in interest-bearing accounts and securities is 0.2% of assets, under the one-third limit.
Pass
Receivables
6.41%
Below 49%
Money owed to the company is 6.4% of assets, under the 49% limit.
Pass
Revenue purity
0.17%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Vulcan Materials clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 29%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VMC's ethical verdict changes
Today VMC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 5 Nov 2026: it trades above our $200.70 fair value estimate, moderate competitive moat.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 42.3% above the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +10% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $200.70, with a range of $200.70 to $230.81, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Roadstone Supplier Priced Beyond the Boom
Think of a quarry that only sells when governments and builders are flush. Vulcan Materials sits at the heart of that cycle, shifting aggregates across the United States at a forward multiple of 26.8 times. Revenue growth of 7 percent and a 14 percent profit margin look respectable, yet the shares sit 26 percent above our fair value of 214 dollars, so we pass.
The moderate moat and clean ethical screen do not change the arithmetic. At 288 dollars the market already prices in steady expansion that construction spending rarely delivers year after year. ROE of 13 percent is adequate, not exceptional, and leaves little cushion if volumes soften.
Cyclical businesses often look most expensive right before demand flattens. Here the premium leaves investors exposed to any slowdown in infrastructure or housing, regardless of the buy-rated analyst targets. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VMC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup · changed$297.69+12.3%Entry 17
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329.
2026-10-29Accumulation$265.00+5.0%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Accumulation$252.40+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Accumulation$252.40+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$252.40+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$252.40+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$252.40+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$252.40+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$252.40+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $329.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
